BCL2 and cancer: TRIM17 exerts its pro-apoptotic function in part by mediating the targeted degradation of MCL-1, an anti-apoptotic protein of the BCL-2 family protein that plays a critical role in the survival of most cell types and contributes to chemoresistance in many cancers [39].